|
1
|
Irani S and Dehghan A: The expression and
functional significance of vascular endothelial-cadherin, CD44, and
vimentin in oral squamous cell carcinoma. J Int Soc Prev Community
Dent. 8:110–117. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hu J, Mirshahidi S, Simental A, Lee SC, De
Andrade Filho PA, Peterson NR, Duerksen-Hughes P and Yuan X: Cancer
stem cell self-renewal as a therapeutic target in human oral
cancer. Oncogene. 38:5440–5456. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Akbari-Birgani S, Paranjothy T, Zuse A,
Janikowski T, Cieślar-Pobuda A, Likus W, Urasińska E, Schweizer F,
Ghavami S, Klonisch T and Łos MJ: Cancer stem cells,
cancer-initiating cells and methods for their detection. Drug
Discov Today. 21:836–842. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Teixeira MG and Corrêa L: Quality
assessment of prognostic studies using cancer stem cell markers in
oral squamous cell carcinoma. Appl Immunohistochem Mol Morphol.
26:e61–e69. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baniebrahimi G, Mir F and Khanmohammadi R:
Cancer stem cells and oral cancer: Insights into molecular
mechanisms and therapeutic approaches. Cancer Cell Int. 20:1132020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ram R, Brasch HD, Dunne JC, Davis PF, Tan
ST and Itinteang T: The identification of three cancer stem cell
subpopulations within moderately differentiated lip squamous cell
carcinoma. Front Surg. 4:122017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lei Y, Zhang D, Yu J, Dong H, Zhang J and
Yang S: Corrigendum to ‘targeting autophagy in cancer stem cells as
an anticancer therapy’ [Canc. Lett. 393 (2017) 33-39]. Cancer Lett.
416:1492018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Annett S and Robson T: Targeting cancer
stem cells in the clinic: Current status and perspectives.
Pharmacol Ther. 187:13–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Singh D, Minz AP and Sahoo SK:
Nanomedicine-mediated drug targeting of cancer stem cells. Drug
Discov Today. 22:952–959. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hazawa M, Lin DC, Handral H, Xu L, Chen Y,
Jiang YY, Mayakonda A, Ding LW, Meng X, Sharma A, et al: ZNF750 is
a lineage-specific tumour suppressor in squamous cell carcinoma.
Oncogene. 36:2243–2254. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pan L, Yang H, Xu C, Chen S, Meng Z, Li K
and Chen H: ZNF750 inhibited the malignant progression of oral
squamous cell carcinoma by regulating tumor vascular
microenvironment. Biomed Pharmacother. 105:566–572. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Otsuka R, Akutsu Y, Sakata H, Hanari N,
Murakami K, Kano M, Toyozumi T, Takahashi M, Matsumoto Y, Sekino N,
et al: ZNF750 expression is a potential prognostic biomarker in
esophageal squamous cell carcinoma. Oncology. 94:142–148. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu X, Yang Y, Xu C, Yang H, Chen S and
Chen H: RNA sequencing analysis of the CAL-27 cell response to
over-expressed ZNF750 gene revealed an extensive regulation on cell
cycle. Biomed Pharmacother. 118:1093772019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Beca F, Kensler K, Glass B, Schnitt SJ,
Tamimi RM and Beck AH: EZH2 protein expression in normal breast
epithelium and risk of breast cancer: Results from the nurses'
health studies. Breast Cancer Res. 19:212017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Salcido CD, Larochelle A, Taylor BJ,
Dunbar CE and Varticovski L: Molecular characterisation of side
population cells with cancer stem cell-like characteristics in
small-cell lung cancer. Br J Cancer. 102:1636–1644. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miao ZF, Zhao TT, Wang ZN, Xu YY, Mao XY,
Wu JH, Liu XY, Xu H, You Y and Xu HM: Influence of different
hypoxia models on metastatic potential of SGC-7901 gastric cancer
cells. Tumour Biol. 35:6801–6808. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang
J, Zhang G, Wang X, Dong Z, Chen F and Cui H: Targeting cancer stem
cell pathways for cancer therapy. Signal Transduct Target Ther.
5:82020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kaufhold S, Garbán H and Bonavida B: Yin
Yang 1 is associated with cancer stem cell transcription factors
(SOX2, OCT4, BMI1) and clinical implication. J Exp Clin Cancer Res.
35:842016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ellis BL, Potts PR and Porteus MH:
Creating higher titer lentivirus with caffeine. Hum Gene Ther.
22:93–100. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lohberger B, Rinner B, Stuendl N, Absenger
M, Liegl-Atzwanger B, Walzer SM, Windhager R and Leithner A:
Aldehyde dehydrogenase 1, a potential marker for cancer stem cells
in human sarcoma. PLoS One. 7:e436642012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yoshihama R, Yamaguchi K, Imajyo I, Mine
M, Hiyake N, Akimoto N, Kobayashi Y, Chigita S, Kumamaru W,
Kiyoshima T, et al: Expression levels of SOX2, KLF4 and brachyury
transcription factors are associated with metastasis and poor
prognosis in oral squamous cell carcinoma. Oncol Lett.
11:1435–1446. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kaczorowska A, Miękus N, Stefanowicz J and
Adamkiewicz-Drożyńska E: Selected matrix metalloproteinases (MMP-2,
MMP-7) and their inhibitor (TIMP-2) in adult and pediatric cancer.
Diagnostics (Basel). 10:5472020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zou B, Sun S, Qi X and Ji P: Aldehyde
dehydrogenase activity is a cancer stem cell marker of tongue
squamous cell carcinoma. Mol Med Rep. 5:1116–1120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Krishnamurthy S and Nör JE: Head and neck
cancer stem cells. J Dent Res. 91:334–340. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han J, Fujisawa T, Husain SR and Puri RK:
Identification and characterization of cancer stem cells in human
head and neck squamous cell carcinoma. BMC Cancer. 14:1732014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Swain N, Thakur M, Pathak J and Swain B:
SOX2, OCT4 and NANOG: The core embryonic stem cell pluripotency
regulators in oral carcinogenesis. J Oral Maxillofac Pathol.
24:368–373. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fu TY, Hsieh IC, Cheng JT, Tsai MH, Hou
YY, Lee JH, Liou HH, Huang SF, Chen HC, Yen LM, et al: Association
of OCT4, SOX2, and NANOG expression with oral squamous cell
carcinoma progression. J Oral Pathol Med. 45:89–95. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Basati G, Mohammadpour H and Emami Razavi
A: Association of high expression levels of SOX2, NANOG, and OCT4
in gastric cancer tumor tissues with progression and poor
prognosis. J Gastrointest Cancer. 51:41–47. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ooki A, Dinalankara W, Marchionni L, Tsay
JJ, Goparaju C, Maleki Z, Rom WN, Pass HI and Hoque MO:
Epigenetically regulated PAX6 drives cancer cells toward a
stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma.
Oncogene. 37:5967–5981. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Panaccione A, Zhang Y, Mi Y, Mitani Y, Yan
G, Prasad ML, McDonald WH, El-Naggar AK, Yarbrough WG and Ivanov
SV: Chromosomal abnormalities and molecular landscape of
metastasizing mucinous salivary adenocarcinoma. Oral Oncol.
66:38–45. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Papale M, Ferretti E, Battaglia G,
Bellavia D, Mai A and Tafani M: EZH2, HIF-1, and their inhibitors:
An overview on pediatric cancers. Front Pediatr. 6:3282018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Varier RA and Timmers HT: Histone lysine
methylation and demethylation pathways in cancer. Biochim Biophys
Acta. 1815:75–89. 2011.PubMed/NCBI
|
|
35
|
Shafiei S, Kalantari E, Saeednejad Zanjani
L, Abolhasani M, Asadi Lari MH and Madjd Z: Increased expression of
DCLK1, a novel putative CSC maker, is associated with tumor
aggressiveness and worse disease-specific survival in patients with
bladder carcinomas. Exp Mol Pathol. 108:164–172. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pickup MW, Mouw JK and Weaver VM: The
extracellular matrix modulates the hallmarks of cancer. EMBO Rep.
15:1243–1253. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stanciu AE, Zamfir-Chiru-Anton A, Stanciu
MM, Popescu CR and Gheorghe DC: Imbalance between matrix
metalloproteinases and tissue inhibitors of metalloproteinases
promotes invasion and metastasis of head and neck squamous cell
carcinoma. Clin Lab. 63:1613–1620. 2017. View Article : Google Scholar : PubMed/NCBI
|
